Showing results (1-10 of 237) with videos related to
Sort By:
Pageof 24
The Lancet. Oncology|March 25, 2016
Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trialEdward F Patz, Erin Greco, Constantine Gatsonis, et al.JAMA Internal Medicine|December 11, 2013
Overdiagnosis in low-dose computed tomography screening for lung cancerEdward F Patz, Paul Pinsky, Constantine Gatsonis, et al.Annals of Internal Medicine|September 10, 2014
National Lung Screening Trial findings by age: Medicare-eligible versus under-65 populationPaul F Pinsky, David S Gierada, William Hocking, et al.American Journal of Epidemiology|October 10, 2019
Thyroid Incidentalomas in Association With Low-Dose Computed Tomography in the National Lung Screening TrialHolli A Loomans-Kropp, Barbara K Dunn, Barnett S Kramer, et al.Biostatistics (Oxford, England)|February 23, 2010
Transparency and reproducibility in data analysis: the Prostate Cancer Prevention TrialStuart G Baker, Amy K Darke, Paul Pinsky, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Integration of biomarkers and imagingEdward F PatzRadiologic Clinics of North America|September 15, 2012
Future trends in lung cancer diagnosisJared D Christensen, Edward F PatzLung Cancer (Amsterdam, Netherlands)|November 26, 2002
PET imaging in patients with bronchioloalveolar cell carcinomaLaura E Heyneman, Edward F PatzAnnals of Epidemiology|November 22, 2017
Validation: a critical step in bringing biomarkers to clinical fruitionSudhir Srivastava, Barnett S KramerPageof 24